Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial

Long‐term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open‐label trial

Abstract The primary objective of this trial (SP1042; NCT02582866) was to assess long‐term safety and tolerability of lacosamide monotherapy (200‐600 mg/day) in adults with focal (partial‐onset) seizures or generalized tonic‐clonic seizures (without clear focal origin). This Phase III, long‐term, op...

Full description

Bibliographic Details
Main Authors: Elinor Ben‐Menachem, Jacqueline Dominguez, József Szász, Cynthia Beller, Charles Howerton, Lori Jensen, Carrie McClung, Robert Roebling, Björn Steiniger‐Brach
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Epilepsia Open
Subjects:
epilepsy
lacosamide
long‐term
monotherapy
safety
tolerability
Online Access:https://doi.org/10.1002/epi4.12522

Internet

https://doi.org/10.1002/epi4.12522

Similar Items